Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Depression and antidepressants: molecular and cellular aspects.

Lanni C, Govoni S, Lucchelli A, Boselli C.

Cell Mol Life Sci. 2009 Sep;66(18):2985-3008. doi: 10.1007/s00018-009-0055-x. Review.

PMID:
19521663
2.

[Depression and neuroplasticity. Interaction of nervous, endocrine and immune systems].

Cassano P, Argibay P.

Medicina (B Aires). 2010;70(2):185-93. Review. Spanish.

PMID:
20447905
3.

Future antidepressants: what is in the pipeline and what is missing?

Bosker FJ, Westerink BH, Cremers TI, Gerrits M, van der Hart MG, Kuipers SD, van der Pompe G, ter Horst GJ, den Boer JA, Korf J.

CNS Drugs. 2004;18(11):705-32. Review.

PMID:
15330686
4.

Depression, antidepressants, and peripheral blood components.

Fisar Z, Raboch J.

Neuro Endocrinol Lett. 2008 Feb;29(1):17-28. Review.

PMID:
18283265
5.

New strategies in the development of antidepressants: towards the modulation of neuroplasticity pathways.

Vidal R, Pilar-Cuéllar F, dos Anjos S, Linge R, Treceño B, Vargas VI, Rodriguez-Gaztelumendi A, Mostany R, Castro E, Diaz A, Valdizán EM, Pazos A.

Curr Pharm Des. 2011;17(5):521-33. Review.

PMID:
21375480
6.

Antidepressants: past, present and future.

Vetulani J, Nalepa I.

Eur J Pharmacol. 2000 Sep 29;405(1-3):351-63. Review.

PMID:
11033340
7.

Opiates as antidepressants.

Berrocoso E, Sánchez-Blázquez P, Garzón J, Mico JA.

Curr Pharm Des. 2009;15(14):1612-22. Review.

PMID:
19442177
8.
9.

[Pharmacological characterization and mechanisms of the novel antidepressive- and/or anxiolytic-like substances identified from Perillae Herba].

Tsuji M, Miyagawa K, Takeuchi T, Takeda H.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2008 Aug;28(4):159-67. Review. Japanese.

PMID:
18800619
10.

[Affective disorders and antidepressant drugs: Therapeutic innovations].

Fakra E, Azorin JM, Adida M, Da Fonseca D, Kaladjian A, Pringuey D.

Encephale. 2010 Dec;36 Suppl 6:S183-7. doi: 10.1016/S0013-7006(10)70055-5. Review. French.

PMID:
21237354
11.

Experimental methods for evaluation of psychotropic agents in rodents: II-Antidepressants.

Bhattacharya SK, Satyan KS, Ramanathan M.

Indian J Exp Biol. 1999 Feb;37(2):117-23. Review.

PMID:
10641129
12.
13.

Does neurotropin-3 have a therapeutic implication in major depression?

Pae CU, Marks DM, Han C, Patkar AA, Steffens D.

Int J Neurosci. 2008 Nov;118(11):1515-22. doi: 10.1080/00207450802174589. Review.

PMID:
18853330
14.

Invited review: the evolution of antidepressant mechanisms.

Slattery DA, Hudson AL, Nutt DJ.

Fundam Clin Pharmacol. 2004 Feb;18(1):1-21. Review.

PMID:
14748749
15.

[Clinical pharmacology of antidepressants (review)].

Mosolov SN.

Ter Arkh. 1998;70(10):71-6. Review. Russian. No abstract available.

PMID:
9864810
16.

Antiapoptotic and neurotrophic effects of antidepressants: a review of clinical and experimental studies.

Drzyzga ŁR, Marcinowska A, Obuchowicz E.

Brain Res Bull. 2009 Jun 30;79(5):248-57. doi: 10.1016/j.brainresbull.2009.03.009. Review.

PMID:
19480984
17.

Regulation of adult hippocampal neurogenesis: relevance to depression.

Vaidya VA, Fernandes K, Jha S.

Expert Rev Neurother. 2007 Jul;7(7):853-64. Review.

PMID:
17610392
18.

Endocannabinoids in the treatment of mood disorders: evidence from animal models.

Bambico FR, Duranti A, Tontini A, Tarzia G, Gobbi G.

Curr Pharm Des. 2009;15(14):1623-46. Review.

PMID:
19442178
19.

[New options in the treatment of depression].

Frieling H, Hillemacher T, Demling JH, Kornhuber J, Bleich S.

Fortschr Neurol Psychiatr. 2007 Nov;75(11):641-52. Review. German.

PMID:
17366379
20.

Gene expression profiling reveals complex changes in the olfactory bulbectomy model of depression after chronic treatment with antidepressants.

Takahashi K, Saitoh A, Yamada M, Maruyama Y, Hirose N, Kamei J, Yamada M.

J Pharmacol Sci. 2008 Nov;108(3):320-34.

Supplemental Content

Support Center